Doctor’s Hang Up Blamed for Fatal Pulmonary Embolism
No one likes being put on hold, but, as one physician found out, there is no substitute for direct communication when a patient’s life is in jeopardy.
Diagnosis & Disease Information
Iron Supplements in CKD: An Update
Iron from dietary sources is inadequate to address functional iron deficiency associated with ESA use.
A Clinical Dilemma: What is Normal?
The concept of what is “normal” enters into nearly every aspect of clinical decision making. For physicians to declare something abnormal and make a diagnosis, they must first know what normal is.
Program Benefits Poor PCa Patients
Providing free care to economically disadvantaged prostate cancer patients may eliminate racial and ethnic disparities in the use of health resources related to prostate cancer, new findings suggest.
Percutaneous Nephrolithotomy in Renal Allografts Safe
Percutaneous nephrolithotomy (PNL) in transplanted kidneys is safe and effective, according to a report in The Journal of Urology (2008; published online ahead of print).
Age Alone Should Not Deter ADT Use
BOSTON—Age alone should not matter when deciding whether to combine long-term androgen deprivation therapy (ADT) and radiation therapy in men with high-risk prostate cancer, a study found.
Personalized RCC Treatment May Be Superior
Clinicians may be able to improve survival rates among patients with renal cell carcinoma (RCC) by tailoring treatments according to risk levels of malignancies, study findings suggest.
No Benefit from Renal Stents
PHILADELPHIA—Placing renal artery stents in patients with atherosclerotic renovascular disease is not associated with improved outcomes when compared with optimal medical therapy alone.
Nutrients Fail to Prevent Prostate Cancer
Selenium and vitamin E supplements, taken alone or together, do not prevent prostate cancer, according to an early analysis of data from the Selenium and Vitamin C Cancer Prevention Trial.
ADT-Related Anxiety Linked to Elevated PSA
Men with elevated serum PSA levels prior to beginning androgen deprivation therapy (ADT) for prostate cancer are nearly eight times more likely to experience anxiety after starting ADT, researchers reported.
- Loading...
Loading...
Loading... 
Loading...